Enhanced phasic GABA inhibition during the repair phase of stroke: A novel therapeutic target

Brain

Volumn 139, Issue 2, 2016, Pages 468-480

  Hiu, Takeshi ^a,b   Farzampour, Zoya ^a   Paz, Jeanne T ^a,c   Wang, Eric Hou Jen ^a,b   Badgely, Corrine ^a   Olson, Andrew ^a   Micheva, Kristina D ^a   Wang, Gordon ^a   Lemmens, Robin ^a,b,d   Tran, Kevin V ^a,b   Nishiyama, Yasuhiro ^a,b   Liang, Xibin ^a,b   Hamilton, Scott A ^a,b   O'Rourke, Nancy ^a   Smith, Stephen J ^a   Huguenard, John R ^a   Bliss, Tonya M ^a,b   Steinberg, Gary K ^a,b,e  

^a STANFORD UNIVERSITY   (United States)

^b Stanford Medicine Children s Health   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain repair; phasic GABA; stroke; zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; ZOLPIDEM; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; PYRIDINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; C57BL MOUSE; CONVALESCENCE; DRUG DELIVERY SYSTEM; DRUG EFFECTS; NEOCORTEX; NERVE CELL INHIBITION; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROKE; TRENDS;

ANIMALS; DRUG DELIVERY SYSTEMS; GABA-A RECEPTOR AGONISTS; MALE; MICE; MICE, INBRED C57BL; NEOCORTEX; NEURAL INHIBITION; ORGAN CULTURE TECHNIQUES; PYRIDINES; RECEPTORS, GABA-A; RECOVERY OF FUNCTION; STROKE;

EID: 84977071786     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv360     Document Type: Article

References (55)

1. Allen NB, Kaltenbach L, Goldstein LB, Olson DM, Smith EE, Peterson ED, et al. Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines-Stroke 2003-2010. Stroke 2012; 43: 1858-64
2. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, et al. Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci USA 2011; 108: 13287-92
3. Bacci A, Rudolph U, Huguenard JR, Prince DA. Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses. J Neurosci 2003; 23: 9664-74./
4. Benavides J, Peny B, Ruano D, Vitorica J, Scatton B. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 1993; 604: 240-50
5. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
6. Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P, et al. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc 2009; 4: 1560-4
7. Carmichael ST. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol 2006; 59: 735-42
8. Chandra D, Halonen LM, Linden AM, Procaccini C, Hellsten K, Homanics GE, et al. Prototypic GABA(A) receptor agonist muscimol acts preferentially through forebrain high-affinity binding sites. Neuropsychopharmacology 2010; 35: 999-1007
9. Cheng MY, Wang EH, Woodson WJ, Wang S, Sun G, Lee AG, et al. Optogenetic neuronal stimulation promotes functional recovery after stroke. Proc Natl Acad Sci USA 2014; 111: 12913-8
10. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 2010; 468: 305-9
11. Cohen L, Chaaban B, Habert MO. Transient improvement of aphasia with zolpidem. N Engl J Med 2004; 350: 949-50
12. Crestani F, Martin JR, Mohler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 2000; 131: 1251-4
13. Derdikman D, Hildesheim R, Ahissar E, Arieli A, Grinvald A. Imaging spatiotemporal dynamics of surround inhibition in the barrels somatosensory cortex. J Neurosci 2003; 23: 3100-5
14. Dijkhuizen RM, Ren J, Mandeville JB, Wu O, Ozdag FM, Moskowitz MA, et al. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci USA 2001; 98: 12766-71
15. Fagiolini M, Fritschy JM, Low K, Mohler H, Rudolph U, Hensch TK. Specific GABAA circuits for visual cortical plasticity. Science 2004; 303: 1681-3
16. Farkas RH, Unger EF, Temple R. Zolpidem and driving impairment-identifying persons at risk. N Engl J Med 2013; 369: 689-91
17. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005; 6: 215-29
18. Foeller E, Celikel T, Feldman DE. Inhibitory sharpening of receptive fields contributes to whisker map plasticity in rat somatosensory cortex. J Neurophysiol 2005; 94: 4387-400
19. Fritschy JM, Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995; 359: 154-94
20. Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thenot JP, Morselli PL. Pharmacokinetics, brain distribution and pharmacoelectrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 1989; 248: 1283-8
21. Glykys J, Mann EO, Mody I. Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?. J Neurosci 2008; 28: 1421-6
22. Green AR, Hainsworth AH, Jackson DM. GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 2000; 39: 1483-94
23. Hall SD, Yamawaki N, Fisher AE, Clauss RP, Woodhall GL, Stanford IM. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke-a case report. Clin Neurophysiol 2010; 121: 549-55
24. Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005; 6: 877-88
25. Hensch TK, Stryker MP. Columnar architecture sculpted by GABA circuits in developing cat visual cortex. Science 2004; 303: 1678-81
26. Hines RM, Davies PA, Moss SJ, Maguire J. Functional regulation of GABAA receptors in nervous system pathologies. Curr Opin Neurobiol 2012; 22: 552-8
27. Hu H, Jonas P. A supercritical density of Na( + ) channels ensures fast signaling in GABAergic interneuron axons. Nat Neurosci 2014; 17: 686-93
28. Huguenard JR, Prince DA. Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 1994; 71: 2576-81
29. Jolkkonen J, Gallagher NP, Zilles K, Sivenius J. Behavioral deficits and recovery following transient focal cerebral ischemia in rats: glutamatergic and GABAergic receptor densities. Behav Brain Res 2003; 138: 187-200
30. Kaila K, Price TJ, Payne JA, Mody I, Puskarjov M, Voipio J. Cationchloride cotransporters in neuronal development, plasticity and disease. Nat Rev Neurosci 2014; 15: 637-54
31. Lehmann K, Steinecke A, Bolz J. GABA through the ages: regulation of cortical function and plasticity by inhibitory interneurons. Neural Plast 2012; 2012: 892784
32. Li S, Overman JJ, Katsman D, Kozlov SV, Donnelly CJ, Twiss JL, et al. An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci 2010; 13: 1496-504
33. Lyden PD, Hedges B. Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke 1992; 23: 1463-9; discussion 9-70
34. Mendez P, Bacci A. Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast 2011; 2011: 976856
35. Micheva KD, Busse B, Weiler NC, O'Rourke N, Smith SJ. Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers. Neuron 2010; 68: 639-53
36. Micheva KD, Smith SJ. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 2007; 55: 25-36
37. Mikkelsen B, Birket-Smith E, Bradt S, Holm P, Bparm, Lung M, et al. Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch Neurol 1976; 33: 322-5
38. Mittmann T, Qu M, Zilles K, Luhmann HJ. Long-term cellular dysfunction after focal cerebral ischemia: in vitro analyses. Neuroscience 1998; 85: 15-27
39. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 2009; 10: 861-72
40. Neumann-Haefelin T, Hagemann G, Witte OW. Cellular correlates of neuronal hyperexcitability in the vicinity of photochemically induced cortical infarcts in rats in vitro. Neurosci Lett 1995; 193: 101-4
41. Neumann-Haefelin T, Staiger JF, Redecker C, Zilles K, Fritschy JM, Mohler H, et al. Immunohistochemical evidence for dysregulation of the GABAergic system ipsilateral to photochemically induced cortical infarcts in rats. Neuroscience 1998; 87: 871-9
42. Nudo RJ, Wise BM, SiFuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996; 272: 1791-4
43. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 2004
44. Paz JT, Christian CA, Parada I, Prince DA, Huguenard JR. Focal cortical infarcts alter intrinsic excitability and synaptic excitation in the reticular thalamic nucleus. J Neurosci 2010; 30: 5465-79
45. Paz JT, Davidson TJ, Frechette ES, Delord B, Parada I, Peng K, et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci 2013; 16: 64-70
46. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39: 5-17
47. Qu M, Buchkremer-Ratzmann I, Schiene K, Schroeter M, Witte OW, Zilles K. Bihemispheric reduction of GABAA receptor binding following focal cortical photothrombotic lesions in the rat brain. Brain Res 1998; 813: 374-80
48. Redecker C, Luhmann HJ, Hagemann G, Fritschy JM, Witte OW. Differential downregulation of GABAA receptor subunits in widespread brain regions in the freeze-lesion model of focal cortical malformations. J Neurosci 2000; 20: 5045-53
49. Rudolph U, Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 2011; 10: 685-97
50. Salin PA, Prince DA. Electrophysiological mapping of GABAA receptor-mediated inhibition in adult rat somatosensory cortex. J Neurophysiol 1996; 75: 1589-600
51. Schiene K, Bruehl C, Zilles K, Qu M, Hagemann G, Kraemer M, et al. Neuronal hyperexcitability and reduction of GABAA-receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 1996; 16: 906-14
52. Shames JL, Ring H. Transient reversal of anoxic brain injuryrelated minimally conscious state after zolpidem administration: a case report. Arch Phys Med Rehabil 2008; 89: 386-8
53. Verheugen JA, Fricker D, Miles R. Noninvasive measurements of the membrane potential and GABAergic action in hippocampal interneurons. J Neurosci 1999; 19: 2546-55
54. Vlainic J, Pericic D. Zolpidem is a potent anticonvulsant in adult and aged mice. Brain Res 2010; 1310: 181-8
55. Zheng W, Knudsen EI. Gabaergic inhibition antagonizes adaptive adjustment of the owl's auditory space map during the initial phase of plasticity. J Neurosci 2001; 21: 4356-65.